Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics

Neuropsychopharmacology

Volumn 22, Issue 2, 2000, Pages 140-147

  Carboni, Ezio ^a   Rolando, Maria T P ^a   Silvagni, Alessandra ^a   Di Chiara, Gaetano ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Antipsychotics; Bed nucleus of stria terminalis (BNST); Clozapine; Dopamine; Microdialysis

Indexed keywords

3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMPEROZIDE; BIMG 80; CLOZAPINE; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PRAZOSIN; RACLOPRIDE; RISPERIDONE; RITANSERIN; SEROTONIN 2 ANTAGONIST; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STRIA TERMINALIS;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; DOPAMINE; KINETICS; MALE; MICRODIALYSIS; PIPERAZINES; PIRENZEPINE; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE; SEPTAL NUCLEI;

EID: 0034142286     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00085-8     Document Type: Article

References (31)

1. Alheid G.F., Heimer L. Theories of basal forebrain organization and the "emotional motor system." Prog Brain Res. 107:1996;461-484.
2. Alheid G.F., Heimer L. New perspective in basal forebrain organization of special relevance for neuropsychiatric disorders. The striatopallidal, amygdaloid, and corticopetal components of substantia innominata Neuroscience. 27:1988;1-39.
3. Andersson J.L., Nomikos G.G., Marcus M., Hertel P., Mathé J.M., Svensson T.H. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectively in the mesolimbic dopaminergic system. Naunyn Schmiedebergs's Arch Pharmacol. 352:1995;374-385.
4. Arnt J., Skarsfeldt T. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 18:1998;63-101.
5. Baldessarini R.J., Huston-Lyson D., Campbell A., Marsh E., Cohen B.M. Do central antiadrenergic actions contribute to the atypical properties of clozapine? Br J Psychiat. 160:1992;12-16.
6. Beasley C.M., Tollefson G., Tran P., Satterlee W., Sanger T., Hamilton S. Olanzapine versus placebo and haloperidol. Acute phase results of the North American double-blind olanzapine trial Neuropsychopharmacology. 14:1996;87-96.
7. Bristow J.L., Kramer M.S., Kulagoswski J., Patel S., Ragan I.C., Seabrok G.R. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist. Trends Pharmacol Sci. 18:1997;186-188.
8. Brunello N., Masotto C., Steardo L., Markstein R., Racagni G. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology. 13:1995;177-212.
9. 2 receptors. Implications for drug mechanisms of action Life Sci. 39:1986;2571-2580.
10. Coward D.M. General pharmacology of clozapine. Br J Psychiat. 160:1992;5-11.
11. Deutch A.Y., Duman R.S. The effects of antipsychotic drugs on fos protein expression in the prefrontal cortex - Cellular localization and pharmacological characterization. Neuroscience. 70:1996;377-389.
12. Hall H., Kohler C., Gawell L., Farde L., Sedvall G. Raclopride, a new selective ligand for the dopamine-D2 receptors. Prog Neuropsychopharmacol Biol Psychiat. 12:1988;559-568.
13. Haskins J.T., Muth E.A., Andree T.H. Biochemical and electrophysiological studies on the psychotropic compound, amperozide. Brain Res Bull. 19:1987;465-471.
14. Heimer L., Alheid G.F., Zahm D.S. Basal forebrain organization. An anatomical framework for motor aspects of drive and motivation Kalivas P.W., Barnes C.D. The Mesolimbic Motor Circuit and its Role in Neuropsychiatric disorders. 1993;CRC Press, Boca Raton.
15. Hertel P., Nomikos G.G., Iurlo M., Svensson T.H. Risperidone. Regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain Psychopharmacology. 124:1996;74-86.
16. Imperato A., Di Chiara G. Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci. 5:1985;297-306.
17. Imperato A., Angelucci L. The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats. Psychopharmacol Bull. 25:1989;383-389.
18. Leysen J.E., Gommeren W., Van Gompel P., Wynants J., Janssen P.F., Laduron P.M. Receptor-binding properties in vitro and in vivo of ritanserin. A very potent and long-acting serotonin-S2 antagonist Mol Pharmacol. 27:1985;600-611.
19. 2 receptors in rat striata and mesolimbic tissues using [125]-2′-iodospiperone. Psychopharmacology. 110:1993;27-36.
20. Leysen J.E., Janssen P.M., Megens A.A., Schotte A. Risperidone. A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacological activity J Clin Psychiat. 55:1994;5-12.
21. Malmberg Å, Jackson D.M., Eriksson A., Mohell N. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. Mol Pharmacol. 43:1993;749-754.
22. 2 and serotonin2 pK values. J Pharmacol Exper Ther. 251:1989;238-246.
23. Moghaddam B., Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat. An in vivo microdialysis study Neurochemistry. 54:1990;1755-1760.
24. Nomikos G.G., Iurlo M., Andersson J.L., Kimura K., Svensson T.H. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology. 115:1994;147-156.
25. Paxinos G., Watson C. The Rat Brain Stereotaxic Coordinates. 1982;Academic Press, New York.
26. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain. Contrasting effects of haloperidol and clozapine Neuroscience. 46:1992;315-328.
27. Tohyama M., Taketsuji K. Atlas of Neuroactive Substances and Their Receptor in the Rat. 1998;Oxford University Press, New York.
28. Tork I. Anatomy of the serotonergic system. Ann NY Acad Sci. 600:1991;9-34.
29. 4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
30. Volontè M., Monferini E., Cerutti M., Fodritto F., Borsini F. BIMG 80, a novel potential antipsychotic drug. evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex J Neurochem. 69:1997;182-190.
31. Xi-Ming L., Perry K.W., Wong D.T., Bymaster F.B. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacology. 136:1998;153-161.